Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
StarTree Extends Real-Time Analytics Capabilities for Observability and Anomaly Detection Use Cases
-
Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
-
ONCOTELIC PRESENTING AT BIOPHARMA NEXUS CONFERENCE SAN DIEGO 2024
-
MEDIA ADVISORY: INTERVIEW OPPORTUNITIES
-
Fobi AI Partners with Verifiction to Enhance Data Verification and Cyber Security Protection
-
Horizon Aircraft Provides Update on Technical Flight Testing Progress
-
TSS, INC. TO REPORT FIRST QUARTER 2024 RESULTS ON TUESDAY, MAY 15th, 2024
-
SRAX Signs Agreement to Merge with DNA Holdings
-
HF Foods Reports First Quarter 2024 Financial Results
-
Treatment.com AI Announces Appointment of Richard Atkins as Chief Operating Officer and Executive Team member
-
Global Mofy Metaverse Pioneers the "Next Generation" of Content Creation with Gausspeed
-
Monster Beverage Corporation Commences Modified Dutch Auction Tender Offer to Purchase Up to $3.0 Billion of Its Outstanding Common Stock
-
Standard Lithium and Equinor Form Partnership to Develop South West Arkansas and East Texas Lithium Projects
-
IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
-
Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
-
Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor Events
-
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
-
Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
-
Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease
-
ArriVent BioPharma Reports First Quarter 2024 Financial Results
-
TytoCare and Urgent Care Association to Host Major Health System Leaders for Rural & Urgent Care Clinic Virtual Summit
-
Gen Z Consumers Are Using Credit More, and Differently, than Their Millennial Counterparts at the Beginning of their Credit Journeys
-
Ingage Adds Integration of Renoworks Pro to Digital Presentation Design and Publishing Tools for Contractors
-
BioAtla to Participate in the Citizens JMP Life Sciences Conference
-
Fulcrum Therapeutics Announces Publication of Results from Phase 2b Clinical Trial of Losmapimod in Facioscapulohumeral muscular dystrophy (ReDUX4) in The Lancet Neurology
-
Intermex Reports First Quarter Results
-
authID Inc. Partners with IDMWORKS to Expand Reach of Its Biometric Identity Platform
-
Heliene and UGE Announce Strategic Partnership and Multiyear Module Supply Agreement
-
ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases
-
60 Degrees Pharmaceuticals Outlines Upcoming Clinical Trial of Tafenoquine in Babesiosis in Letter to Journal of Infectious Diseases
-
Cloudbrink hits the easy button with first ‘personal SASE’ for hybrid workforce
-
Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
-
Form 8.3 - Libertine Holdings plc
-
Presenting on the Emerging Growth Conference 70 Day 2 on May 9 Register Now
-
Treos Bio to Present New Clinical Data on Off-the-Shelf Peptide Immunotherapy for Colorectal Cancer at 2024 ASCO Annual Meeting
-
IntelGenx Announces Voting Results on Election of Directors
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Shoals
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SSR Mining
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health
-
Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference
-
Metasphere Labs Inc. Finalizes Strategic Partnership with Bot Ventures Inc. to Lead in Bitcoin-Based Decentralized Identity Solutions
-
MasterCraft Boat Holdings, Inc. Reports Results for Fiscal 2024 Third Quarter
-
Kornit Digital Reports First Quarter 2024 Results
-
HPQ Silicon Signs MOU With Impact Funding Europe for Collaboration on EU Funding Programs
-
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights
-
Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic Cardiomyopathy
-
Amerigo Announces Q1-2024 Results & Quarterly Dividend
-
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586
